Pipeline: Wiley Chambers, MD, FDA Ophthalmology regulator.

Ocul Surf

Department of Ophthalmology & Vision Sciences, University of California, Davis, USA; PharmaLogic Development Inc., San Rafael, CA, USA. Electronic address:

Published: October 2024

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtos.2024.08.004DOI Listing

Publication Analysis

Top Keywords

pipeline wiley
4
wiley chambers
4
chambers fda
4
fda ophthalmology
4
ophthalmology regulator
4
pipeline
1
chambers
1
fda
1
ophthalmology
1
regulator
1

Similar Publications

Spatial transcriptomics (ST) offers enormous potential to decipher the biological and pathological heterogeneity in precious archival cancer tissues. Traditionally, these tissues have rarely been used and only examined at a low throughput, most commonly by histopathological staining. ST adds thousands of times as many molecular features to histopathological images, but critical technical issues and limitations require more assessment of how ST performs on fixed archival tissues.

View Article and Find Full Text PDF

Intrinsically disordered proteins (IDPs) make up around 30% of eukaryotic proteomes and play a crucial role in cellular processes and in pathological conditions such as neurodegenerative disorders and cancers. However, IDPs exhibit dynamic conformational ensembles and are often involved in the formation of biomolecular condensates. Understanding the function of IDPs is critical to research in many areas of science.

View Article and Find Full Text PDF

Antiviral drugs are essential medications to save the lives of infected people. However, they are under constant threat to become ineffective as viruses evolve quickly. Studying the development of resistance is therefore paramount to understand the impact of mutations on pharmacological treatment and to make informed decisions.

View Article and Find Full Text PDF

Transcriptomic data is often expensive and difficult to generate in large cohorts relative to genomic data; therefore, it is often important to integrate multiple transcriptomic datasets from both microarray- and next generation sequencing (NGS)-based transcriptomic data across similar experiments or clinical trials to improve analytical power and discovery of novel transcripts and genes. However, transcriptomic data integration presents a few challenges including reannotation and batch effect removal. We developed the Gene Expression Data Integration (GEDI) R package to enable transcriptomic data integration by combining existing R packages.

View Article and Find Full Text PDF
Article Synopsis
  • * Recently, there have been great breakthroughs for MS, with new medications being approved, but people with PD still have not gotten new treatments and only have old ones that don't work as well.
  • * Experts from around the world gathered in Toronto to discuss how to improve treatment for PD by learning from what worked for MS, focusing on things like better clinical trials and understanding the diseases better.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!